Jordan J Feld Selected Research

Drug Therapy (Chemotherapy)

6/2017	Treatment of hepatitis B virus with combination therapy now and in the future.
1/2017	Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis.
7/2015	Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.
1/2013	Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations.
9/2012	Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.
7/2010	American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases.
10/2009	Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.
5/2006	Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jordan J Feld Research Topics

Disease

110	Infections 03/2024 - 06/2008
55	Fibrosis (Cirrhosis) 11/2023 - 05/2009
40	Hepatitis C 02/2024 - 08/2005
38	Chronic Hepatitis B 04/2024 - 05/2006
31	Chronic Hepatitis C 03/2024 - 02/2007
22	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 05/2009
17	Hepatitis B 01/2023 - 10/2007
13	Liver Diseases (Liver Disease) 12/2022 - 01/2005
9	Neoplasms (Cancer) 12/2023 - 05/2006
8	COVID-19 05/2023 - 01/2021
8	Hepatitis 05/2023 - 10/2007
8	Virus Diseases (Viral Diseases) 11/2021 - 06/2015
6	Liver Failure 05/2023 - 12/2012
6	Coinfection 11/2021 - 01/2005
6	Disease Progression 01/2021 - 02/2006
5	Reinfection 10/2023 - 12/2010
4	Blister (Bulla) 10/2020 - 01/2018
4	HIV Infections (HIV Infection) 02/2016 - 01/2005
3	Persistent Infection 07/2023 - 01/2019
3	Viremia 11/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 01/2014
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 09/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 01/2010
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2023 - 01/2017
2	Hemorrhage 11/2022 - 09/2014
2	End Stage Liver Disease 01/2020 - 05/2009
2	Nausea 12/2018 - 01/2017
2	Cryoglobulinemia 08/2017 - 11/2015
2	Liver Neoplasms (Liver Cancer) 07/2017 - 01/2017
2	Fatigue 01/2017 - 11/2015
2	Lymphoma (Lymphomas) 01/2013 - 09/2012
1	Substance-Related Disorders (Drug Abuse) 11/2023

Drug/Important Bio-Agent (IBA)

90	Antiviral Agents (Antivirals)IBA 03/2024 - 05/2006
41	InterferonsIBA 01/2024 - 08/2005
28	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 08/2005
21	RNA (Ribonucleic Acid)IBA 01/2024 - 08/2012
19	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 10/2009
18	Hepatitis B e AntigensIBA 04/2024 - 05/2006
17	SofosbuvirIBA 10/2021 - 05/2014
13	Alanine Transaminase (SGPT)IBA 01/2023 - 10/2007
12	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 10/2007
11	velpatasvirIBA 10/2021 - 12/2015
8	VaccinesIBA 01/2023 - 06/2017
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2009
7	glecaprevir and pibrentasvirIBA 12/2022 - 01/2018
7	ombitasvirIBA 10/2020 - 04/2014
7	paritaprevirIBA 10/2020 - 04/2014
7	Ritonavir (Norvir)FDA Link 10/2020 - 04/2014
6	Protease Inhibitors (Protease Inhibitor)IBA 12/2022 - 06/2012
6	dasabuvirIBA 10/2020 - 04/2014
5	CytokinesIBA 01/2024 - 02/2007
5	NucleosidesIBA 09/2023 - 10/2009
5	Tenofovir (Viread)FDA Link 01/2023 - 01/2013
5	AntigensIBA 01/2022 - 07/2010
5	Interferon-gamma (Interferon, gamma)IBA 03/2016 - 01/2012
4	Interferon-alpha (Interferon Alfa)IBA 04/2024 - 01/2010
4	NucleotidesIBA 01/2023 - 05/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2014
4	AntibodiesIBA 01/2021 - 09/2006
3	Opioid Analgesics (Opioids)IBA 03/2024 - 10/2020
3	nasIBA 03/2024 - 01/2019
3	ChemokinesIBA 05/2023 - 01/2016
3	Interferon LambdaIBA 01/2023 - 02/2016
3	EnzymesIBA 01/2023 - 01/2021
3	Alkaline PhosphataseIBA 01/2021 - 06/2008
3	Rituximab (Mabthera)FDA Link 08/2017 - 09/2012
3	Coffee FDA Link 01/2015 - 01/2010
2	entecavir FDA Link 01/2023 - 01/2019
2	Hepatitis C AntibodiesIBA 01/2022 - 01/2016
2	Peptides (Polypeptides)IBA 01/2022 - 03/2016
2	Nucleic AcidsIBA 01/2022 - 01/2021
2	Viral ProteinsIBA 11/2021 - 02/2006
2	Monoclonal AntibodiesIBA 01/2021 - 11/2020
2	Immunoglobulin G (IgG)IBA 11/2020 - 06/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2018
2	ledipasvirIBA 07/2017 - 07/2015
2	sofosbuvir drug combination ledipasvirIBA 07/2017 - 10/2016
2	AlbuminsIBA 12/2016 - 01/2016
2	SimeprevirIBA 02/2016 - 05/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 01/2010
2	telaprevirIBA 04/2014 - 06/2012
1	Neutralizing AntibodiesIBA 04/2024
1	Interleukin-2 (IL2)IBA 12/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2023
1	COVID-19 VaccinesIBA 05/2023
1	COVID-19 vaccine booster shotIBA 05/2023
1	Reverse Transcriptase InhibitorsIBA 12/2022

Therapy/Procedure

101	Therapeutics 04/2024 - 01/2005
14	Liver Transplantation 11/2023 - 12/2012
8	Drug Therapy (Chemotherapy) 06/2017 - 05/2006
5	Aftercare (After-Treatment) 11/2021 - 07/2017
4	Transplantation 10/2023 - 01/2019
4	Retreatment 10/2023 - 01/2021
3	Drug Tapering 01/2021 - 09/2014
3	Duration of Therapy 01/2021 - 02/2016
3	Opiate Substitution Treatment 01/2020 - 12/2016
2	Hepatectomy 05/2023 - 05/2023
2	Subcutaneous Injections 01/2023 - 01/2021
2	Lung Transplantation 08/2022 - 01/2020
2	Stem Cell Transplantation 11/2020 - 10/2009